Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × BI 2536 × Clear all

NCT02211833 2014-08-08

Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung